Medicare Enrolled

Dr. Khashayar Dashtipour, M.D.

Neurology · Loma Linda, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
11370 ANDERSON ST, Loma Linda, CA 92354
9095582880
In practice since 2006 (19 years)
NPI: 1053358457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dashtipour from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dashtipour? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dashtipour

Dr. Khashayar Dashtipour is a neurology specialist in Loma Linda, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dashtipour performed 12,721 Medicare services across 430 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dashtipour received a total of $3,300,336 from 34 pharmaceutical and/or device companies across 2826 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dashtipour is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 8% volume in CA $3,300,336 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,721
Medicare services
Top 8% in CA for neurology
430
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~670 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
5,590 $5 $21
Rimabotulinumtoxinb injection, 100 units
An injection of rimabotulinumtoxinb administered in a dose of 100 units.
4,250 $10 $35
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
2,189 $4 $20
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
359 $125 $420
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
189 $95 $320
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
41 $147 $903
New patient office visit, complex (60-74 min) 37 $151 $597
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
36 $138 $711
Chemical paralysis of salivary glands, bilateral
Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth.
30 $92 $305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,300,336
Total received (2018-2024)
Avg $471,477/year across 7 years
Top 0% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
2,826
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,053,599 (92.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$242,432 (7.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,306 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$321,361
2023
$527,052
2022
$536,318
2021
$449,642
2020
$327,365
2019
$601,640
2018
$536,959

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$83,786
Teva Pharmaceuticals USA, Inc.
$53,427
ABBVIE INC.
$32,811
Kyowa Kirin, Inc.
$28,953
Ipsen Biopharmaceuticals, Inc
$26,035
ACADIA Pharmaceuticals Inc
$24,023
Amneal Pharmaceuticals LLC
$22,528
Neurocrine Biosciences, Inc.
$21,747
Acorda Therapeutics, Inc
$11,119
MITSUBISHI TANABE PHARMA AMERICA, INC.
$9,418
Biogen, Inc.
$6,804
REVANCE THERAPEUTICS, INC.
$218
Boston Scientific Corporation
$179
Merz Pharmaceuticals, LLC
$154
Avion Pharmaceuticals
$124
Medtronic, Inc.
$36
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$572,328
Neurocrine Biosciences, Inc.
$525,797
MDD US Operations, LLC
$369,599
Kyowa Kirin, Inc.
$260,175
ACADIA Pharmaceuticals Inc
$225,530
US WorldMeds, LLC
$192,991
Amneal Pharmaceuticals LLC
$180,006
Acorda Therapeutics, Inc
$170,497
Ipsen Biopharmaceuticals, Inc
$149,409
Adamas Pharmaceuticals, Inc.
$128,928
Sunovion Pharmaceuticals Inc.
$89,641
Neurocrine BioSciences, Inc.
$83,740
Lundbeck LLC
$67,404
ABBVIE INC.
$62,087
AbbVie Inc.
$55,363
Allergan, Inc.
$46,490
Allergan Inc.
$39,911
AbbVie, Inc.
$30,795
Impax Laboratories, Inc.
$26,337
MITSUBISHI TANABE PHARMA AMERICA, INC.
$9,418
Biogen, Inc.
$6,804
Ipsen Innovation
$2,800
Abbott Laboratories
$1,499
Merz Pharmaceuticals, LLC
$1,217
Boston Scientific Corporation
$590
Medtronic USA, Inc.
$316
REVANCE THERAPEUTICS, INC.
$218
Merz North America, Inc.
$167
Avion Pharmaceuticals
$124
Supernus Pharmaceuticals, Inc.
$65
Medtronic, Inc.
$36
CATALYST PHARMACEUTICALS, INC.
$28
Amgen Inc.
$22
Travere Therapeutics, Inc.
$4
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AJOVY · APOKYN · APTIOM · AUSTEDO · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · CREXONT · Cholbam · DAXXIFY · DAYBUE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · FIRDAPSE · GENERAL - DBS · GOCOVRI · General - DBS · Gocovri · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KYNMOBI · LATUDA · MYOBLOC · NORTHERA · NOURIANZ · NUPLAZID · Neuromodulation Dspsbls and Accs · Nourianz · ONGENTYS · Ongentys · PERCEPT PC BRAINSENSE · Proclaim DRG IPG · QULIPTA · RADICAVA · RYTARY · SKYCLARYS · Tavneos · UBRELVY · VYALEV · VYEPTI · Vercise · XADAGO · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in CA.

Looking for a neurology specialist in Loma Linda?
Compare neurologists in the Loma Linda area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
91
Per 100K population
4.2
County median income
$82,184
Nearest hospital
LOMA LINDA UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dashtipour is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dashtipour experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Dashtipour performed 5,590 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dashtipour receive payments from pharmaceutical companies?
Yes. Dr. Dashtipour received a total of $3,300,336 from 34 companies across 2,826 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dashtipour's costs compare to other neurologists in Loma Linda?
Dr. Dashtipour's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dashtipour) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →